BRUNO MAIA

 .

A ómicron a fechar as economias 

europeias e a vacina a encher

 os cofres das farmacêuticas

A cada segundo que passa, Pfizer e Moderna lucram 880€ pela venda das vacinas. Ao contrário do que prometem os arautos do mercado livre, o aumento da produção e a concorrência não baixaram os preços das vacinas.

𝘌𝘴𝘵𝘢𝘮𝘰𝘴 𝘱𝘳𝘦𝘴𝘵𝘦𝘴 𝘢 𝘤𝘰𝘮𝘱𝘭𝘦𝘵𝘢𝘳 𝘶𝘮 𝘢𝘯𝘰 𝘥𝘰 𝘪𝘯𝘪́𝘤𝘪𝘰 𝘥𝘰 𝘱𝘳𝘰𝘤𝘦𝘴𝘴𝘰 𝘥𝘦 𝘷𝘢𝘤𝘪𝘯𝘢𝘤̧𝘢̃𝘰 𝘤𝘰𝘯𝘵𝘳𝘢 𝘢 𝘊𝘰𝘷𝘪𝘥-𝟣𝟫. 𝘌𝘮 𝘗𝘰𝘳𝘵𝘶𝘨𝘢𝘭, 𝘶𝘮 𝘴𝘶𝘤𝘦𝘴𝘴𝘰 𝘪𝘯𝘲𝘶𝘦𝘴𝘵𝘪𝘰𝘯𝘢́𝘷𝘦𝘭: 𝘣𝘢𝘴𝘵𝘢 𝘷𝘦𝘳 𝘱𝘦𝘭𝘰 𝘯𝘶́𝘮𝘦𝘳𝘰 𝘥𝘦 𝘮𝘰𝘳𝘵𝘦𝘴 𝘦 𝘥𝘦 𝘪𝘯𝘵𝘦𝘳𝘯𝘢𝘮𝘦𝘯𝘵𝘰𝘴. 𝘔𝘢𝘴 𝘤𝘦𝘥𝘰, 𝘷𝘢́𝘳𝘪𝘢𝘴 𝘰𝘳𝘨𝘢𝘯𝘪𝘻𝘢𝘤̧𝘰̃𝘦𝘴 𝘪𝘯𝘵𝘦𝘳𝘯𝘢𝘤𝘪𝘰𝘯𝘢𝘪𝘴, 𝘦𝘯𝘵𝘳𝘦 𝘢𝘴 𝘲𝘶𝘢𝘪𝘴 𝘢 𝘖𝘳𝘨𝘢𝘯𝘪𝘻𝘢𝘤̧𝘢̃𝘰 𝘔𝘶𝘯𝘥𝘪𝘢𝘭 𝘥𝘦 𝘚𝘢𝘶́𝘥𝘦 (𝘖𝘔𝘚), 𝘢𝘭𝘦𝘳𝘵𝘢𝘳𝘢𝘮 𝘰𝘴 𝘨𝘰𝘷𝘦𝘳𝘯𝘰𝘴 𝘥𝘰𝘴 𝘱𝘢𝘪́𝘴𝘦𝘴 𝘮𝘢𝘪𝘴 𝘳𝘪𝘤𝘰𝘴 𝘱𝘢𝘳𝘢 𝘢 𝘯𝘦𝘤𝘦𝘴𝘴𝘪𝘥𝘢𝘥𝘦 𝘥𝘦 𝘷𝘢𝘤𝘪𝘯𝘢𝘳 𝘰 𝘮𝘶𝘯𝘥𝘰 𝘵𝘰𝘥𝘰 𝘢𝘰 𝘮𝘦𝘴𝘮𝘰 𝘵𝘦𝘮𝘱𝘰, 𝘴𝘰𝘣 𝘱𝘦𝘯𝘢 𝘥𝘦 𝘥𝘦𝘪𝘹𝘢𝘳𝘮𝘰𝘴 𝘰 𝘷𝘪́𝘳𝘶𝘴 𝘱𝘳𝘰𝘭𝘪𝘧𝘦𝘳𝘢𝘳 𝘦𝘮 𝘢́𝘳𝘦𝘢𝘴 𝘥𝘦 𝘣𝘢𝘪𝘹𝘢 𝘷𝘢𝘤𝘪𝘯𝘢𝘤̧𝘢̃𝘰, 𝘮𝘶𝘵𝘢𝘯𝘥𝘰, 𝘰𝘳𝘪𝘨𝘪𝘯𝘢𝘯𝘥𝘰 𝘯𝘰𝘷𝘢𝘴 𝘷𝘢𝘳𝘪𝘢𝘯𝘵𝘦𝘴 𝘦 𝘳𝘦𝘪𝘯𝘧𝘦𝘤𝘵𝘢𝘯𝘥𝘰 𝘥𝘦 𝘯𝘰𝘷𝘰 𝘢 𝘱𝘰𝘱𝘶𝘭𝘢𝘤̧𝘢̃𝘰 𝘷𝘢𝘤𝘪𝘯𝘢𝘥𝘢. 𝘖 𝘲𝘶𝘦 𝘧𝘪𝘻𝘦𝘳𝘢𝘮 𝘦𝘴𝘴𝘦𝘴 𝘨𝘰𝘷𝘦𝘳𝘯𝘰𝘴? 𝘐𝘨𝘯𝘰𝘳𝘢𝘳𝘢𝘮 𝘰𝘴 𝘢𝘷𝘪𝘴𝘰𝘴, 𝘢𝘤̧𝘢𝘮𝘣𝘢𝘳𝘤𝘢𝘳𝘢𝘮 𝘷𝘢𝘤𝘪𝘯𝘢𝘴 𝘦 𝘦𝘴𝘲𝘶𝘦𝘤𝘦𝘳𝘢𝘮 𝘈́𝘧𝘳𝘪𝘤𝘢! 𝘌𝘵 𝘷𝘰𝘪𝘭𝘢̀... 𝘴𝘶𝘳𝘨𝘪𝘶 𝘢 𝘖𝘮𝘪𝘤𝘳𝘰𝘯. 𝘕𝘰𝘷𝘢 𝘷𝘢𝘳𝘪𝘢𝘯𝘵𝘦, 𝘮𝘶𝘪𝘵𝘰 𝘮𝘢𝘪𝘴 𝘤𝘰𝘯𝘵𝘢𝘨𝘪𝘰𝘴𝘢 𝘦 𝘲𝘶𝘦 𝘢𝘨𝘰𝘳𝘢 𝘨𝘳𝘢𝘴𝘴𝘢 𝘱𝘦𝘭𝘢 𝘌𝘶𝘳𝘰𝘱𝘢!

𝘖𝘴 𝘳𝘦𝘤𝘦𝘯𝘵𝘦𝘴 𝘯𝘶́𝘮𝘦𝘳𝘰𝘴 𝘥𝘢 𝘪𝘯𝘧𝘦𝘤̧𝘢̃𝘰 𝘱𝘰𝘳 𝘚𝘈𝘙𝘚-𝘊𝘰𝘷𝟤 𝘵𝘦̂𝘮 𝘥𝘦𝘪𝘹𝘢𝘥𝘰 𝘰𝘴 𝘦𝘶𝘳𝘰𝘱𝘦𝘶𝘴 𝘱𝘦𝘳𝘱𝘭𝘦𝘹𝘰𝘴: 𝘙𝘦𝘪𝘯𝘰 𝘜𝘯𝘪𝘥𝘰 𝘦 𝘈𝘭𝘦𝘮𝘢𝘯𝘩𝘢 𝘢𝘵𝘪𝘯𝘨𝘪𝘳𝘢𝘮 𝘳𝘦𝘤𝘰𝘳𝘥𝘦𝘴 𝘥𝘪𝘢́𝘳𝘪𝘰𝘴, 𝘐𝘵𝘢́𝘭𝘪𝘢 𝘦 𝘍𝘳𝘢𝘯𝘤̧𝘢 𝘤𝘢𝘮𝘪𝘯𝘩𝘢𝘮 𝘯𝘰 𝘮𝘦𝘴𝘮𝘰 𝘴𝘦𝘯𝘵𝘪𝘥𝘰. 𝘌́ 𝘷𝘦𝘳𝘥𝘢𝘥𝘦 𝘲𝘶𝘦 𝘩𝘢́ 𝘶𝘮𝘢 𝘨𝘪𝘨𝘢𝘯𝘵𝘦𝘴𝘤𝘢 𝘥𝘪𝘧𝘦𝘳𝘦𝘯𝘤̧𝘢 𝘦𝘮 𝘳𝘦𝘭𝘢𝘤̧𝘢̃𝘰 𝘢̀𝘴 𝘷𝘢𝘨𝘢𝘴 𝘢𝘯𝘵𝘦𝘳𝘪𝘰𝘳𝘦𝘴: 𝘰 𝘯𝘶́𝘮𝘦𝘳𝘰 𝘥𝘦 𝘮𝘰𝘳𝘵𝘦𝘴 𝘦 𝘥𝘦 𝘪𝘯𝘵𝘦𝘳𝘯𝘢𝘥𝘰𝘴 𝘦́ 𝘮𝘶𝘪𝘵𝘰 𝘮𝘦𝘯𝘰𝘳 𝘦 𝘪𝘴𝘴𝘰 𝘦́ 𝘧𝘶𝘯𝘥𝘢𝘮𝘦𝘯𝘵𝘢𝘭 𝘱𝘢𝘳𝘢 𝘮𝘢𝘯𝘵𝘦𝘳 𝘴𝘦𝘳𝘷𝘪𝘤̧𝘰𝘴 𝘥𝘦 𝘴𝘢𝘶́𝘥𝘦 𝘦𝘮 𝘧𝘶𝘯𝘤𝘪𝘰𝘯𝘢𝘮𝘦𝘯𝘵𝘰. 𝘕𝘰 𝘦𝘯𝘵𝘢𝘯𝘵𝘰, 𝘢𝘱𝘦𝘴𝘢𝘳 𝘥𝘢 𝘮𝘦𝘯𝘰𝘳 𝘨𝘳𝘢𝘷𝘪𝘥𝘢𝘥𝘦, 𝘷𝘢́𝘳𝘪𝘰𝘴 𝘱𝘢𝘪́𝘴𝘦𝘴 𝘦𝘶𝘳𝘰𝘱𝘦𝘶𝘴 𝘦𝘴𝘵𝘢̃𝘰 𝘫𝘢́ 𝘢 𝘢𝘥𝘰𝘱𝘵𝘢𝘳 𝘯𝘰𝘷𝘢𝘴 𝘮𝘦𝘥𝘪𝘥𝘢𝘴 𝘥𝘦 𝘤𝘰𝘯𝘧𝘪𝘯𝘢𝘮𝘦𝘯𝘵𝘰, 𝘧𝘦𝘤𝘩𝘰 𝘥𝘦 𝘦𝘴𝘤𝘰𝘭𝘢𝘴, 𝘭𝘪𝘮𝘪𝘵𝘢𝘤̧𝘢̃𝘰 𝘥𝘦 𝘴𝘦𝘳𝘷𝘪𝘤̧𝘰𝘴. 𝘌 𝘪𝘴𝘴𝘰 𝘵𝘦𝘮 𝘦𝘧𝘦𝘪𝘵𝘰𝘴 𝘯𝘢 𝘦𝘥𝘶𝘤𝘢𝘤̧𝘢̃𝘰 𝘥𝘢𝘴 𝘤𝘳𝘪𝘢𝘯𝘤̧𝘢𝘴, 𝘯𝘢 𝘦𝘤𝘰𝘯𝘰𝘮𝘪𝘢 𝘥𝘰𝘴 𝘱𝘢𝘪́𝘴𝘦𝘴, 𝘯𝘰 𝘯𝘰𝘳𝘮𝘢𝘭 𝘧𝘶𝘯𝘤𝘪𝘰𝘯𝘢𝘮𝘦𝘯𝘵𝘰 𝘥𝘢𝘴 𝘯𝘰𝘴𝘴𝘢𝘴 𝘴𝘰𝘤𝘪𝘦𝘥𝘢𝘥𝘦𝘴.

𝘏𝘢́ 𝘶𝘮 𝘢𝘯𝘰, 𝘢 𝘖𝘔𝘚 𝘱𝘦𝘥𝘪𝘶 𝘢 𝘢𝘣𝘦𝘳𝘵𝘶𝘳𝘢 𝘥𝘢𝘴 𝘱𝘢𝘵𝘦𝘯𝘵𝘦𝘴 𝘥𝘢𝘴 𝘷𝘢𝘤𝘪𝘯𝘢𝘴 𝘱𝘢𝘳𝘢 𝘧𝘢𝘤𝘪𝘭𝘪𝘵𝘢𝘳 𝘢 𝘥𝘪𝘴𝘵𝘳𝘪𝘣𝘶𝘪𝘤̧𝘢̃𝘰 𝘨𝘭𝘰𝘣𝘢𝘭 𝘥𝘦 𝘷𝘢𝘤𝘪𝘯𝘢𝘴. 𝘈𝘴 𝘧𝘢𝘳𝘮𝘢𝘤𝘦̂𝘶𝘵𝘪𝘤𝘢𝘴 𝘰𝘱𝘶𝘴𝘦𝘳𝘢𝘮-𝘴𝘦 𝘦 𝘰𝘴 𝘨𝘰𝘷𝘦𝘳𝘯𝘰𝘴 𝘥𝘰𝘴 𝘱𝘢𝘪́𝘴𝘦𝘴 𝘳𝘪𝘤𝘰𝘴 𝘧𝘪𝘻𝘦𝘳𝘢𝘮-𝘭𝘩𝘦𝘴 𝘰 𝘧𝘢𝘷𝘰𝘳 𝘥𝘦 𝘱𝘳𝘰𝘵𝘦𝘨𝘦𝘳𝘦𝘮 𝘰𝘴 𝘴𝘦𝘶𝘴 𝘭𝘶𝘤𝘳𝘰𝘴 𝘮𝘪𝘭𝘪𝘰𝘯𝘢́𝘳𝘪𝘰𝘴. 𝘕𝘦𝘯𝘩𝘶𝘮 𝘢𝘳𝘨𝘶𝘮𝘦𝘯𝘵𝘰 𝘱𝘢𝘳𝘢 𝘢 𝘳𝘦𝘤𝘶𝘴𝘢 𝘥𝘢 𝘢𝘣𝘦𝘳𝘵𝘶𝘳𝘢 𝘥𝘢𝘴 𝘱𝘢𝘵𝘦𝘯𝘵𝘦𝘴 𝘴𝘦 𝘮𝘢𝘯𝘵𝘦́𝘮 𝘥𝘦 𝘱𝘦́! 𝘍𝘢𝘭𝘵𝘢 𝘥𝘦 𝘵𝘦𝘤𝘯𝘰𝘭𝘰𝘨𝘪𝘢 𝘱𝘢𝘳𝘢 𝘢 𝘱𝘳𝘰𝘥𝘶𝘤̧𝘢̃𝘰? 𝘚𝘦 𝘵𝘪𝘷𝘦𝘴𝘴𝘦𝘮 𝘢𝘣𝘦𝘳𝘵𝘰 𝘢𝘴 𝘱𝘢𝘵𝘦𝘯𝘵𝘦𝘴 𝘯𝘰 𝘪𝘯𝘪́𝘤𝘪𝘰 𝘥𝘰 𝘢𝘯𝘰, 𝘱𝘰𝘳 𝘦𝘴𝘵𝘢 𝘢𝘭𝘵𝘶𝘳𝘢 𝘫𝘢́ 𝘴𝘦 𝘵𝘪𝘯𝘩𝘢 𝘪𝘯𝘴𝘵𝘢𝘭𝘢𝘥𝘰 𝘤𝘢𝘱𝘢𝘤𝘪𝘥𝘢𝘥𝘦 𝘯𝘰𝘶𝘵𝘳𝘰𝘴 𝘭𝘰𝘤𝘢𝘪𝘴! 𝘓𝘰𝘨𝘪́𝘴𝘵𝘪𝘤𝘢? 𝘘𝘶𝘢𝘭𝘪𝘥𝘢𝘥𝘦 𝘥𝘰 𝘱𝘳𝘰𝘥𝘶𝘵𝘰? 𝘍𝘢𝘭𝘵𝘢 𝘥𝘦 𝘴𝘶𝘱𝘦𝘳𝘷𝘪𝘴𝘢̃𝘰? 𝘌𝘴𝘲𝘶𝘦𝘤𝘦𝘳𝘢𝘮-𝘴𝘦 𝘲𝘶𝘦 𝘢 𝘐́𝘯𝘥𝘪𝘢 (𝘶𝘮 𝘥𝘰𝘴 𝘱𝘢𝘪́𝘴𝘦𝘴 𝘲𝘶𝘦 𝘱𝘦𝘥𝘪𝘶 𝘢 𝘢𝘣𝘦𝘳𝘵𝘶𝘳𝘢 𝘥𝘢𝘴 𝘱𝘢𝘵𝘦𝘯𝘵𝘦𝘴) 𝘦́ 𝘰 𝘮𝘢𝘪𝘰𝘳 𝘱𝘳𝘰𝘥𝘶𝘵𝘰𝘳 𝘮𝘶𝘯𝘥𝘪𝘢𝘭 𝘥𝘦 𝘮𝘦𝘥𝘪𝘤𝘢𝘮𝘦𝘯𝘵𝘰𝘴? 𝘌𝘯𝘵𝘢̃𝘰 𝘰𝘴 𝘮𝘦𝘥𝘪𝘤𝘢𝘮𝘦𝘯𝘵𝘰𝘴 𝘲𝘶𝘦 𝘤𝘰𝘯𝘴𝘶𝘮𝘪𝘮𝘰𝘴 𝘩𝘰𝘫𝘦 𝘯𝘰𝘴 𝘱𝘢𝘪́𝘴𝘦𝘴 𝘳𝘪𝘤𝘰𝘴 𝘦 𝘲𝘶𝘦 𝘷𝘦̂𝘮, 𝘮𝘢𝘪𝘰𝘳𝘪𝘵𝘢𝘳𝘪𝘢𝘮𝘦𝘯𝘵𝘦, 𝘥𝘦 𝘧𝘢́𝘣𝘳𝘪𝘤𝘢𝘴 𝘭𝘰𝘤𝘢𝘭𝘪𝘻𝘢𝘥𝘢𝘴 𝘯𝘢 𝘈́𝘴𝘪𝘢 𝘯𝘢̃𝘰 𝘵𝘦̂𝘮 𝘲𝘶𝘢𝘭𝘪𝘥𝘢𝘥𝘦 𝘦 𝘯𝘢̃𝘰 𝘴𝘢̃𝘰 𝘴𝘶𝘱𝘦𝘳𝘷𝘪𝘴𝘪𝘰𝘯𝘢𝘥𝘰𝘴? 𝘍𝘢𝘭𝘵𝘢 𝘥𝘦 𝘪𝘯𝘧𝘳𝘢𝘦𝘴𝘵𝘳𝘶𝘵𝘶𝘳𝘢 𝘥𝘦 𝘴𝘢𝘶́𝘥𝘦 𝘱𝘢𝘳𝘢 𝘥𝘪𝘴𝘵𝘳𝘪𝘣𝘶𝘪𝘳 𝘢𝘴 𝘷𝘢𝘤𝘪𝘯𝘢𝘴? 𝘖 𝘮𝘦𝘴𝘮𝘰 𝘢𝘳𝘨𝘶𝘮𝘦𝘯𝘵𝘰 𝘶𝘵𝘪𝘭𝘪𝘻𝘢𝘥𝘰 𝘯𝘰 𝘤𝘢𝘴𝘰 𝘥𝘢 𝘚𝘐𝘋𝘈 𝘦 𝘲𝘶𝘦 𝘤𝘢𝘪𝘶 𝘱𝘰𝘳 𝘵𝘦𝘳𝘳𝘢 𝘲𝘶𝘢𝘯𝘥𝘰 𝘴𝘦 𝘱𝘦𝘳𝘤𝘦𝘣𝘦𝘶 𝘲𝘶𝘦 𝘢 𝘢𝘥𝘦𝘴𝘢̃𝘰 𝘥𝘰𝘴 𝘱𝘰𝘷𝘰𝘴 𝘈𝘧𝘳𝘪𝘤𝘢𝘯𝘰𝘴 𝘢𝘰𝘴 𝘮𝘦𝘥𝘪𝘤𝘢𝘮𝘦𝘯𝘵𝘰𝘴 𝘦𝘳𝘢 𝘱𝘦𝘭𝘰 𝘮𝘦𝘯𝘰𝘴 𝘵𝘢̃𝘰 𝘣𝘰𝘢 𝘲𝘶𝘢𝘯𝘵𝘰 𝘢 𝘥𝘰𝘴 𝘱𝘢𝘪́𝘴𝘦𝘴 𝘳𝘪𝘤𝘰𝘴.

𝘕𝘰 𝘧𝘪𝘯𝘢𝘭 𝘥𝘦 𝟤𝟢𝟤𝟣, 𝘰𝘴 𝘱𝘢𝘪́𝘴𝘦𝘴 𝘮𝘢𝘪𝘴 𝘱𝘰𝘣𝘳𝘦𝘴 𝘥𝘪𝘴𝘵𝘳𝘪𝘣𝘶𝘪́𝘳𝘢𝘮 𝘢𝘱𝘦𝘯𝘢𝘴 𝟫,𝟥 𝘷𝘢𝘤𝘪𝘯𝘢𝘴 𝘱𝘰𝘳 𝘤𝘢𝘥𝘢 𝟣𝟢𝟢 𝘱𝘦𝘴𝘴𝘰𝘢𝘴, 𝘢𝘰 𝘱𝘢𝘴𝘴𝘰 𝘲𝘶𝘦 𝘯𝘰𝘴 𝘱𝘢𝘪́𝘴𝘦𝘴 𝘳𝘪𝘤𝘰𝘴 𝘴𝘦 𝘥𝘪𝘴𝘵𝘳𝘪𝘣𝘶𝘪́𝘳𝘢𝘮 𝟣𝟧𝟧 𝘷𝘢𝘤𝘪𝘯𝘢𝘴 𝘱𝘰𝘳 𝘤𝘢𝘥𝘢 𝟣𝟢𝟢 (𝘴𝘪𝘮, 𝘮𝘢𝘪𝘴 𝘷𝘢𝘤𝘪𝘯𝘢𝘴 𝘲𝘶𝘦 𝘱𝘦𝘴𝘴𝘰𝘢𝘴). 𝘋𝘢𝘴 𝟩𝟢𝟢 𝘮𝘪𝘭𝘩𝘰̃𝘦𝘴 𝘥𝘦 𝘥𝘰𝘴𝘦𝘴 𝘱𝘳𝘦𝘷𝘪𝘴𝘵𝘢𝘴 𝘱𝘢𝘳𝘢 𝘤𝘩𝘦𝘨𝘢𝘳 𝘢𝘰𝘴 𝘱𝘢𝘪́𝘴𝘦𝘴 𝘮𝘢𝘪𝘴 𝘱𝘰𝘣𝘳𝘦𝘴 𝘢𝘵𝘦́ 𝘢𝘰 𝘧𝘪𝘯𝘢𝘭 𝘥𝘰 𝘢𝘯𝘰, 𝘤𝘩𝘦𝘨𝘢𝘳𝘢𝘮 𝘢𝘵𝘦́ 𝘩𝘰𝘫𝘦 𝘢𝘱𝘦𝘯𝘢𝘴 𝟦𝟢 𝘮𝘪𝘭𝘩𝘰̃𝘦𝘴 (𝘞𝘪𝘯𝘯𝘪𝘦 𝘉𝘺𝘢𝘯𝘺𝘪𝘮𝘢, 𝘥𝘢 𝘖𝘕𝘜). 𝘈𝘵𝘦́ 𝘢̀ 𝘥𝘢𝘵𝘢, 𝘯𝘢 𝘌𝘶𝘳𝘰𝘱𝘢 𝘧𝘰𝘳𝘢𝘮 𝘤𝘰𝘮𝘱𝘳𝘢𝘥𝘢𝘴 𝟦,𝟨 𝘮𝘪𝘭 𝘮𝘪𝘭𝘩𝘰̃𝘦𝘴 𝘥𝘦 𝘥𝘰𝘴𝘦𝘴 𝘱𝘢𝘳𝘢 𝟦𝟦𝟪 𝘮𝘪𝘭𝘩𝘰̃𝘦𝘴 𝘥𝘦 𝘱𝘦𝘴𝘴𝘰𝘢𝘴.

𝘖𝘴 𝘱𝘦𝘥𝘪𝘥𝘰𝘴 𝘥𝘦 𝘢𝘣𝘦𝘳𝘵𝘶𝘳𝘢 𝘥𝘢𝘴 𝘱𝘢𝘵𝘦𝘯𝘵𝘦𝘴 𝘧𝘰𝘳𝘢𝘮 𝘨𝘦𝘯𝘦𝘳𝘢𝘭𝘪𝘻𝘢𝘥𝘰𝘴, 𝘥𝘢𝘴 𝘕𝘢𝘤̧𝘰̃𝘦𝘴 𝘜𝘯𝘪𝘥𝘢𝘴 𝘢̀ 𝘖𝘔𝘚, 𝘥𝘦 𝘈𝘯𝘵𝘰́𝘯𝘪𝘰 𝘎𝘶𝘵𝘦𝘳𝘳𝘦𝘴 𝘢𝘰 𝘗𝘢𝘱𝘢, 𝘱𝘢𝘴𝘴𝘢𝘯𝘥𝘰 𝘱𝘰𝘳 𝘵𝘰𝘥𝘢𝘴 𝘢𝘴 𝘰𝘳𝘨𝘢𝘯𝘪𝘻𝘢𝘤̧𝘰̃𝘦𝘴 𝘲𝘶𝘦 𝘦𝘴𝘵𝘢̃𝘰 𝘯𝘰 𝘵𝘦𝘳𝘳𝘦𝘯𝘰 (𝘦𝘮 𝘈́𝘧𝘳𝘪𝘤𝘢) 𝘩𝘢́ 𝘷𝘢́𝘳𝘪𝘰𝘴 𝘢𝘯𝘰𝘴 𝘦 𝘤𝘰𝘯𝘩𝘦𝘤𝘦𝘮 𝘣𝘦𝘮 𝘢𝘴 𝘱𝘰𝘱𝘶𝘭𝘢𝘤̧𝘰̃𝘦𝘴 𝘥𝘦𝘴𝘵𝘦𝘴 𝘱𝘢𝘪́𝘴𝘦𝘴. 𝘈𝘴 𝘳𝘦𝘤𝘶𝘴𝘢𝘴 𝘥𝘰𝘴 𝘱𝘢𝘪́𝘴𝘦𝘴 𝘳𝘪𝘤𝘰𝘴 𝘮𝘢𝘯𝘵𝘦̂𝘮-𝘴𝘦. 𝘈 𝘊𝘰𝘮𝘪𝘴𝘴𝘢̃𝘰 𝘌𝘶𝘳𝘰𝘱𝘦𝘪𝘢, 𝘤𝘰𝘮 𝘰 𝘢𝘱𝘰𝘪𝘰 𝘥𝘰𝘴 𝘨𝘰𝘷𝘦𝘳𝘯𝘰𝘴 𝘦𝘶𝘳𝘰𝘱𝘦𝘶𝘴, 𝘯𝘢̃𝘰 𝘴𝘰́ 𝘱𝘦𝘳𝘮𝘪𝘵𝘪𝘶 𝘤𝘰𝘮𝘰 𝘱𝘳𝘰𝘮𝘰𝘷𝘦𝘶 𝘦𝘴𝘵𝘢 𝘱𝘰𝘳𝘯𝘰𝘨𝘳𝘢́𝘧𝘪𝘤𝘢 𝘢𝘴𝘤𝘦𝘯𝘤̧𝘢̃𝘰 𝘥𝘦 𝘭𝘶𝘤𝘳𝘰𝘴, 𝘢𝘴𝘴𝘪𝘯𝘢𝘯𝘥𝘰 𝘤𝘰𝘯𝘵𝘳𝘢𝘵𝘰𝘴 𝘰𝘱𝘢𝘤𝘰𝘴 𝘤𝘰𝘮 𝘢𝘴 𝘧𝘢𝘳𝘮𝘢𝘤𝘦̂𝘶𝘵𝘪𝘤𝘢𝘴, 𝘮𝘢𝘯𝘵𝘦𝘯𝘥𝘰 𝘶𝘮𝘢 𝘱𝘢𝘳𝘵𝘦 𝘥𝘢 𝘱𝘰𝘱𝘶𝘭𝘢𝘤̧𝘢̃𝘰 𝘮𝘶𝘯𝘥𝘪𝘢𝘭 𝘦𝘹𝘤𝘭𝘶𝘪́𝘥𝘢 𝘥𝘢𝘴 𝘷𝘢𝘤𝘪𝘯𝘢𝘴 𝘦 𝘱𝘳𝘦𝘫𝘶𝘥𝘪𝘤𝘢𝘯𝘥𝘰 𝘢 𝘴𝘶𝘢𝘴 𝘱𝘳𝘰́𝘱𝘳𝘪𝘢𝘴 𝘦𝘤𝘰𝘯𝘰𝘮𝘪𝘢𝘴.

𝘌 𝘴𝘦 𝘥𝘶́𝘷𝘪𝘥𝘢𝘴 𝘩𝘰𝘶𝘷𝘦𝘴𝘴𝘦 𝘴𝘰𝘣𝘳𝘦 𝘢𝘴 𝘱𝘳𝘪𝘰𝘳𝘪𝘥𝘢𝘥𝘦𝘴 𝘥𝘢 𝘊𝘰𝘮𝘪𝘴𝘴𝘢̃𝘰 𝘌𝘶𝘳𝘰𝘱𝘦𝘪𝘢, 𝘣𝘢𝘴𝘵𝘢 𝘭𝘦𝘳 𝘰 𝘤𝘰𝘯𝘵𝘳𝘢𝘵𝘰 𝘲𝘶𝘦 𝘢𝘴𝘴𝘪𝘯𝘰𝘶 𝘤𝘰𝘮 𝘢 𝘊𝘶𝘳𝘦𝘝𝘢𝘤, 𝘲𝘶𝘦 𝘦𝘴𝘵𝘢𝘣𝘦𝘭𝘦𝘤𝘦 𝘰 𝘱𝘢𝘨𝘢𝘮𝘦𝘯𝘵𝘰 𝘥𝘦 𝘪𝘯𝘥𝘦𝘮𝘯𝘪𝘻𝘢𝘤̧𝘰̃𝘦𝘴 𝘢̀ 𝘧𝘢𝘳𝘮𝘢𝘤𝘦̂𝘶𝘵𝘪𝘤𝘢 𝘯𝘰 𝘤𝘢𝘴𝘰 𝘥𝘦 𝘴𝘶𝘳𝘨𝘪𝘳𝘦𝘮 𝘦𝘧𝘦𝘪𝘵𝘰𝘴 𝘴𝘦𝘤𝘶𝘯𝘥𝘢́𝘳𝘪𝘰𝘴 𝘥𝘢 𝘷𝘢𝘤𝘪𝘯𝘢 𝘰𝘶 𝘤𝘰𝘯𝘤𝘦𝘥𝘦 𝘢̀ 𝘧𝘢𝘳𝘮𝘢𝘤𝘦̂𝘶𝘵𝘪𝘤𝘢 𝘰 𝘱𝘰𝘥𝘦𝘳 𝘥𝘦 𝘥𝘦𝘤𝘪𝘥𝘪𝘳 𝘴𝘦 𝘢 𝘜𝘯𝘪𝘢̃𝘰 𝘌𝘶𝘳𝘰𝘱𝘦𝘪𝘢 𝘱𝘰𝘥𝘦 𝘦𝘯𝘷𝘪𝘢𝘳 𝘷𝘢𝘤𝘪𝘯𝘢𝘴 𝘱𝘢𝘳𝘢 𝘈́𝘧𝘳𝘪𝘤𝘢.

𝘈 𝘤𝘢𝘥𝘢 𝘴𝘦𝘨𝘶𝘯𝘥𝘰 𝘲𝘶𝘦 𝘱𝘢𝘴𝘴𝘢, 𝘗𝘧𝘪𝘻𝘦𝘳 𝘦 𝘔𝘰𝘥𝘦𝘳𝘯𝘢 𝘭𝘶𝘤𝘳𝘢𝘮 𝟪𝟪𝟢€ 𝘱𝘦𝘭𝘢 𝘷𝘦𝘯𝘥𝘢 𝘥𝘢𝘴 𝘷𝘢𝘤𝘪𝘯𝘢𝘴. 𝘚𝘢̃𝘰 𝟧𝟤.𝟪𝟢𝟢€ 𝘱𝘰𝘳 𝘮𝘪𝘯𝘶𝘵𝘰, 𝟥.𝟣𝟨𝟪.𝟢𝟢𝟢€ 𝘱𝘰𝘳 𝘩𝘰𝘳𝘢, 𝟩𝟨.𝟢𝟥𝟤.𝟢𝟢𝟢€ 𝘱𝘰𝘳 𝘥𝘪𝘢, 𝘮𝘢𝘪𝘴 𝘥𝘦 𝟤 𝘮𝘪𝘭 𝘮𝘪𝘭𝘩𝘰̃𝘦𝘴 𝘱𝘰𝘳 𝘮𝘦̂𝘴! (𝘗𝘦𝘰𝘱𝘭𝘦’𝘴 𝘝𝘢𝘤𝘤𝘪𝘯𝘦 𝘈𝘭𝘭𝘪𝘢𝘯𝘤𝘦). 𝘈𝘰 𝘤𝘰𝘯𝘵𝘳𝘢́𝘳𝘪𝘰 𝘥𝘰 𝘲𝘶𝘦 𝘱𝘳𝘰𝘮𝘦𝘵𝘦𝘮 𝘰𝘴 𝘢𝘳𝘢𝘶𝘵𝘰𝘴 𝘥𝘰 𝘮𝘦𝘳𝘤𝘢𝘥𝘰 𝘭𝘪𝘷𝘳𝘦, 𝘰 𝘢𝘶𝘮𝘦𝘯𝘵𝘰 𝘥𝘢 𝘱𝘳𝘰𝘥𝘶𝘤̧𝘢̃𝘰 𝘦 𝘢 𝘤𝘰𝘯𝘤𝘰𝘳𝘳𝘦̂𝘯𝘤𝘪𝘢 𝘯𝘢̃𝘰 𝘣𝘢𝘪𝘹𝘢𝘳𝘢𝘮 𝘰𝘴 𝘱𝘳𝘦𝘤̧𝘰𝘴 𝘥𝘢𝘴 𝘷𝘢𝘤𝘪𝘯𝘢𝘴. 𝘗𝘧𝘪𝘻𝘦𝘳 𝘦 𝘔𝘰𝘥𝘦𝘳𝘯𝘢 𝘢𝘶𝘮𝘦𝘯𝘵𝘢𝘳𝘢𝘮 𝘰 𝘱𝘳𝘦𝘤̧𝘰 𝘤𝘰𝘣𝘳𝘢𝘥𝘰 𝘢̀ 𝘜𝘯𝘪𝘢̃𝘰 𝘌𝘶𝘳𝘰𝘱𝘦𝘪𝘢, 𝘯𝘰 𝘴𝘦𝘨𝘶𝘯𝘥𝘰 𝘤𝘰𝘯𝘵𝘳𝘢𝘵𝘰 𝘲𝘶𝘦 𝘢𝘴𝘴𝘪𝘯𝘢𝘳𝘢𝘮 𝘢𝘮𝘣𝘢𝘴 𝘢𝘴 𝘱𝘢𝘳𝘵𝘦𝘴. 𝘖 𝘨𝘳𝘢́𝘧𝘪𝘤𝘰 𝘴𝘦𝘨𝘶𝘪𝘯𝘵𝘦 𝘪𝘭𝘶𝘴𝘵𝘳𝘢 𝘦𝘴𝘴𝘢𝘴 𝘥𝘪𝘧𝘦𝘳𝘦𝘯𝘤̧𝘢𝘴:

𝘛𝘰𝘥𝘢 𝘦𝘴𝘵𝘢 𝘵𝘳𝘪𝘴𝘵𝘦 𝘩𝘪𝘴𝘵𝘰́𝘳𝘪𝘢 𝘴𝘦 𝘳𝘦𝘴𝘶𝘮𝘦 𝘯𝘶𝘮𝘢 𝘴𝘪𝘮𝘱𝘭𝘦𝘴 𝘧𝘳𝘢𝘴𝘦: 𝘱𝘢𝘳𝘢 𝘱𝘳𝘰𝘵𝘦𝘨𝘦𝘳 𝘰𝘴 𝘭𝘶𝘤𝘳𝘰𝘴 𝘥𝘢𝘴 𝘧𝘢𝘳𝘮𝘢𝘤𝘦̂𝘶𝘵𝘪𝘤𝘢𝘴, 𝘰𝘴 𝘱𝘢𝘪́𝘴𝘦𝘴 𝘳𝘪𝘤𝘰𝘴 𝘥𝘦𝘪𝘹𝘢𝘮 𝘰𝘴 𝘈𝘧𝘳𝘪𝘤𝘢𝘯𝘰𝘴 𝘥𝘦𝘴𝘱𝘳𝘰𝘵𝘦𝘨𝘪𝘥𝘰𝘴 𝘦 𝘱𝘳𝘦𝘫𝘶𝘥𝘪𝘤𝘢𝘮 𝘢𝘴 𝘴𝘶𝘢𝘴 𝘱𝘳𝘰́𝘱𝘳𝘪𝘢𝘴 𝘦𝘤𝘰𝘯𝘰𝘮𝘪𝘢𝘴. 𝘈 𝘴𝘰𝘭𝘶𝘤̧𝘢̃𝘰 𝘵𝘢𝘮𝘣𝘦́𝘮 𝘦́ 𝘴𝘪𝘮𝘱𝘭𝘦𝘴: 𝘣𝘢𝘴𝘵𝘢 𝘤𝘶𝘮𝘱𝘳𝘪𝘳 𝘰𝘴 𝘢𝘤𝘰𝘳𝘥𝘰𝘴 𝘪𝘯𝘵𝘦𝘳𝘯𝘢𝘤𝘪𝘰𝘯𝘢𝘪𝘴 𝘥𝘦 𝘤𝘰𝘮𝘦́𝘳𝘤𝘪𝘰 (𝘤𝘰𝘯𝘷𝘦𝘯𝘤̧𝘢̃𝘰 𝘥𝘦 𝘋𝘰𝘩𝘢) 𝘦 𝘢𝘣𝘳𝘪𝘳 𝘢𝘴 𝘱𝘢𝘵𝘦𝘯𝘵𝘦𝘴, 𝘤𝘰𝘯𝘧𝘰𝘳𝘮𝘦 𝘦𝘴𝘵𝘢́ 𝘱𝘳𝘦𝘷𝘪𝘴𝘵𝘰 𝘦𝘮 𝘴𝘪𝘵𝘶𝘢𝘤̧𝘰̃𝘦𝘴 𝘥𝘦 𝘦𝘮𝘦𝘳𝘨𝘦̂𝘯𝘤𝘪𝘢 𝘴𝘢𝘯𝘪𝘵𝘢́𝘳𝘪𝘢. 𝘗𝘰𝘳 𝘦𝘯𝘲𝘶𝘢𝘯𝘵𝘰, 𝘧𝘪𝘤𝘢𝘮𝘰𝘴 𝘢 𝘷𝘦𝘳 𝘢 𝘰́𝘮𝘪𝘤𝘳𝘰𝘯 𝘢 𝘧𝘦𝘤𝘩𝘢𝘳 𝘢𝘴 𝘦𝘤𝘰𝘯𝘰𝘮𝘪𝘢𝘴 𝘦𝘶𝘳𝘰𝘱𝘦𝘪𝘢𝘴 𝘦 𝘢 𝘷𝘢𝘤𝘪𝘯𝘢 𝘢 𝘦𝘯𝘤𝘩𝘦𝘳 𝘰𝘴 𝘤𝘰𝘧𝘳𝘦𝘴 𝘥𝘢𝘴 𝘧𝘢𝘳𝘮𝘢𝘤𝘦̂𝘶𝘵𝘪𝘤𝘢𝘴.

* Médico neurologista, ativista pela legalização da cannabis e da morte assistida

IN "ESQUERDA" - 19/12/21 

 .